绞股蓝治疗糖尿病的效应成分群及作用机制研究进展

诸夔妞，寿旗扬，田雨闪，谷贵章，胡奇杰，杨红霞，陈晓平，王新财; ZHU Kui-niu; SHOU Qi-yang; TIAN Yu-shan; GU Gui-zhang; HU Qi-jie; YANG Hong-xia; CHEN Xiao-ping; WANG Xin-cai

温馨提示：建议您使用Chrome80、火狐74+、IE9+浏览器，当您的浏览器版本过低，可能会影响部分功能正常使用。

主办：天津药物研究院中国药学会

微信公众号

网站二维码

2025年6月11日 10:27 星期三

首页 > 过刊浏览>2020年第51卷第8期 >2020,51(8):2248-2257. DOI:10.7501/j.issn.0253-2670.2020.08.036

绞股蓝治疗糖尿病的效应成分群及作用机制研究进展

诸夔妞
诸夔妞
湖州市食品药品检验研究院, 浙江湖州 313000
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
寿旗扬
寿旗扬
浙江中医药大学第二临床医学院, 浙江杭州 310053
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
田雨闪
田雨闪
中国药科大学江苏省中药评价与转化重点实验室, 江苏南京 211198
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
谷贵章
谷贵章
湖州市食品药品检验研究院, 浙江湖州 313000
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
胡奇杰
胡奇杰
湖州市食品药品检验研究院, 浙江湖州 313000
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
杨红霞
杨红霞
湖州市食品药品检验研究院, 浙江湖州 313000
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
陈晓平
陈晓平
湖州市食品药品检验研究院, 浙江湖州 313000
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
王新财
王新财
湖州市食品药品检验研究院, 浙江湖州 313000
通讯作者.
Email: clerk2003@sohu.com
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找

Research progress on bioactive component groups and mechanisms of Gynostemma pentaphyllum for treatment of diabetes

ZHU Kui-niu
ZHU Kui-niu
Huzhou Institute for Food and Drug Control, Huzhou 313000, China
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
SHOU Qi-yang
SHOU Qi-yang
The 2nd Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou 310053, China
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
TIAN Yu-shan
TIAN Yu-shan
Jiangsu Key Laboratory of TCM Evaluation and Translational Research, China Pharmaceutical University, Nanjing 211198, China
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
GU Gui-zhang
GU Gui-zhang
Huzhou Institute for Food and Drug Control, Huzhou 313000, China
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
HU Qi-jie
HU Qi-jie
Huzhou Institute for Food and Drug Control, Huzhou 313000, China
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
YANG Hong-xia
YANG Hong-xia
Huzhou Institute for Food and Drug Control, Huzhou 313000, China
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
CHEN Xiao-ping
CHEN Xiao-ping
Huzhou Institute for Food and Drug Control, Huzhou 313000, China
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找
WANG Xin-cai
WANG Xin-cai
Huzhou Institute for Food and Drug Control, Huzhou 313000, China
Contact Author.
Email: clerk2003@sohu.com
在期刊界中查找
在Google Scholar中查找
在百度中查找
在PubMed中查找
在本站中查找

发布日期：2020-04-19

摘要
图/表
访问统计
PDF预览
参考文献
相似文献
引证文献
附件

[关键词]

绞股蓝 ; 效应成分群 ; 糖尿病 ; 降血糖 ; 作用机制

[摘要]

糖尿病是一种以慢性高血糖为主要特征的代谢性疾病。绞股蓝Gynostemma pentaphyllum作为传统的药食两用中药品种之一，具有多种药理活性。近年来，绞股蓝在治疗糖尿病方面的研究取得了较大进展，其作用机制的研究也日趋深入。对2004年以来绞股蓝及绞股蓝皂苷、多糖、粗提物等效应成分群治疗糖尿病的药理作用，以及绞股蓝抑制糖苷酶活性、改善胰岛素抵抗、调节糖脂代谢、调节肠道菌群、抗氧化等几种可能的作用机制进行了综述，以期为绞股蓝治疗糖尿病的活性成分及分子机制的进一步研究和绞股蓝的开发和应用提供参考。

[Key word]

Gynostemma pentaphyllum (Thunb.) Makino ; bioactive component groups ; diabetes ; hypoglycemic effect ; mechanisms

[Abstract]

Diabetes mellitus is a systemic metabolic disease characterized by chronic hyperglycemia. Gynostemma pentaphyllum served as one of the traditional Chinese medicinal and edible herbs has a variety of pharmacological properties. In recent years, great progress has been achieved on the treatment of diabetes, and the research on its potential mechanisms are gradually deepened. In this study, the antidiabetic effects of G. pentaphyllum and the bioactive component groups including gypenosides, polysaccharides and crude extracts, and the possible molecular mechanisms, such as inhibiting glycosidase activity, improving insulin resistance, anti-oxidation, regulating glycolipid metabolism and gut microbiota, were summarized from 2004 to 2019. This review provides the guidance for the further study on the active components and molecular mechanisms in treating diabetes, and the reference for the development and application of G. pentaphyllum.

[中图分类号]

R282

[基金项目]

国家自然科学基金资助项目（81873047）；湖州市公益性技术应用研究重点项目（2018GZ03）

引用本文 / Get Citation

诸夔妞,寿旗扬,田雨闪,谷贵章,胡奇杰,杨红霞,陈晓平,王新财.绞股蓝治疗糖尿病的效应成分群及作用机制研究进展[J].中草药,2020,51(8):2248-2257

分享 / Share

文章指标 / Article Metrics

点击次数: 1869

下载次数: 1569

Html阅读次数: 0

引用次数: 0

历史 / History

收稿日期: 2019-11-12

在线发布日期: 2020-04-19

[1] International Diabetes Federation. IDF Diabetes Atlas:8th edition [M]. Brussels:International Diabetes Federation, 2017.

[2] Stein S A, Lamos E M, Davis S N. A review of the efficacy and safety of oral antidiabetic drugs[J]. Expert Opin Drug Saf, 2013, 12(2):153-175.

[3] Roussel R, Lorraine J, Rodriguez A, et al. Overview of data concerning the safe use of antihyperglycemic medications in type 2 diabetes mellitus and chronic kidney disease[J]. Adv Ther, 2015, 32(11):1029-1064.

[4] Wang Z C, Zhao X X, Liu X Y, et al. Anti-diabetic activity evaluation of a polysaccharide extracted from Gynostemma pentaphyllum[J]. Int J Biol Macromol, 2019, doi:10.1016/j.ijbiomac.2018.12.231.

[5] Jeenduang N, Sangkaew B, Chantaracha P, et al. APOE and CETP TaqIB polymorphisms influence metabolic responses to Hibiscus sabdariffa L. and Gynostemma pentaphyllum Makino tea consumption in hypercholesterolemic subjects[J]. Asia Pac J Clin Nutr, 2017, 26(2):368-378.

[6] Shen C Y, Shi M M, Yang H L, et al. Inhibitory effects of multi-components from Gynostemma pentaphyllum (Thunb.) Makino on macrophage foam cell formation exhibit multi-target characteristics[J]. J Funct Foods, 2019, doi:10.1016/j.jff.2019.103451.

[7] Xing S F, Liu L H, Zu M L, et al. The inhibitory effect of gypenoside stereoisomers, gypenoside L and gypenoside LI, isolated from Gynostemma pentaphyllum on the growth of human lung cancer A549 cells[J]. J Ethnopharmacol, 2018, doi:10.1016/j.jep.2018.03.012.

[8] Megalli S, Davies N M, Roufogalis B D. Anti- hyperlipidemic and hypoglycemic effects of Gynostemma pentaphyllum in the Zucker fatty rat[J]. J Pharm Pharm Sci, 2006, 9(3):281-291.

[9] Ge M, Ma S F, Tao L, et al. The effect of gypenosides on cardiac function and expression of cytoskeletal genes of myocardium in diabetic cardiomyopathy rats[J]. Am J Chin Med, 2009, 37(6):1059-1068.

[10] 林臻桢, 陈彤. 绞股蓝皂甙对实验性糖尿病小鼠的降糖作用研究[J]. 龙岩学院学报, 2011, 29(增刊):51-53.

[11] 张琼, 黄晓飞, 翟文海. 绞股蓝总皂苷对2型糖尿病小鼠糖脂代谢水平及肝脏自噬基因表达的影响[J]. 时珍国医国药, 2018, 29(2):325-327.

[12] Lokman E F, Gu H F, Wan M W N, et al. Evaluation of antidiabetic effects of the traditional medicinal plant Gynostemma pentaphyllum and the possible mechanisms of insulin release[J]. Evid-Based Compl Alt, 2015, doi:10.1155/2015/120572.

[13] 赵世印, 邱华, 贺琴, 等. 绞股蓝皂苷对2型糖尿病合并非酒精性脂肪性肝病模型大鼠肝纤维化影响[J]. 医药导报, 2014, 33(2):156-159.

[14] 贺琴, 李刚, 李芳, 等. 绞股蓝皂苷对2型糖尿病合并非酒精性脂肪性肝病大鼠葡萄糖和脂质代谢的影响[J]. 世界中西医结合杂志, 2017, 12(3):337-342.

[15] 赵涛, 乐静, 李传静, 等. 绞股蓝总皂苷对2型糖尿病大鼠游离脂肪酸代谢的影响及改善胰岛素抵抗相关机制研究[J]. 安徽医药, 2017, 21(1):42-45.

[16] 潘泓, 张飞亚, 张璐, 等. 绞股蓝总皂苷对糖尿病肾脏病大鼠巢蛋白的影响[J]. 中华中医药杂志, 2016, 31(11):4827-4830.

[17] Zhang H J, Ji B P, Chen G, et al. A combination of grape seed-derived procyanidins and gypenosides alleviates insulin resistance in mice and HepG2 cells[J]. J Food Sci, 2009, 74(1):1-7.

[18] 张霞, 雷飞飞, 李芳, 等. 绞股蓝皂苷联合银杏叶提取物对2型糖尿病合并NAFLD大鼠脂肪肝程度的影响[J]. 中国肝脏病杂志:电子版, 2015, 7(1):55-58.

[19] 赵琴, 李刚, 李芳, 等. 绞股蓝皂苷联合银杏叶提取物对2型糖尿病并非酒精性脂肪性肝病大鼠肝组织和血浆H2S的影响[J]. 中医学报, 2017, 32(3):360-364.

[20] Norberg A, Hoa N K, Liepinsh E, et al. A novel insulin-releasing substance, phanoside, from the plant Gynostemma pentaphyllum[J]. J Biol Chem, 2004, 279(40):41361-41367.

[21] Hoa N K, Norberg A, Sillard R, et al. The possible mechanisms by which phanoside stimulates insulin secretion from rat islets[J]. J Endocrinol, 2007, 192(2):389-394.

[22] Lundqvist L C E, Rattigan D, Ehtesham E, et al. Profiling and activity screening of dammarane-type triterpen saponins from Gynostemma pentaphyllum with glucose-dependent insulin secretory activity[J]. Sci Rep-UK, 2019, 9(1):627-636.

[23] 魏守蓉, 薛存宽, 何学斌, 等. 绞股蓝多糖降血糖作用的实验研究[J]. 中国老年学杂志, 2005, 25(4):418-420.

[24] 杜小燕, 侯颖, 覃华, 等. 绞股蓝多糖对2型糖尿病大鼠血糖的影响及其机制初步研究[J]. 科学技术与工程, 2011, 11(24):5754-5758.

[25] 姜羌美, 万珊珊, 郎志芳. 绞股蓝与普罗布考联合应用对糖尿病肾病大鼠炎性因子的影响[J]. 牡丹江医学院学报, 2015, 36(1):21-23.

[26] Fitzenberger E, Deusing D J, Wittkop A, et al. Effects of plant extracts on the reversal of glucose-induced impairment of stress-resistance in Caenorhabditis elegans [J]. Plant Food Hum Nutr, 2014, 69(1):78-84.

[27] 黄晓飞, 宋烨, 宋成武, 等. 绞股蓝不同组分的降血糖活性研究[J]. 湖北中医杂志, 2013, 35(6):67-69.

[28] Hoa N K, Phan D V, Thuan N D, et al. Screening of the hypoglycemic effect of eight Vietnamese herbal drugs[J]. Method Find Exp Clin, 2009, 31(3):165-169.

[29] 欧守珍, 莫燕娜, 陈世民, 等. 海南绞股蓝乙醇提取物的降血糖作用[J]. 中国热带医学, 2014, 14(1):38-40.

[30] 董义, 王斯慧, 曾里, 等. 六种保健食品原料的辅助降血糖功效研究[J]. 食品研究与开发, 2014, 35(23):121-124.

[31] Yassin K, Huyen V T T, Hoa K N, et al. Herbal extract of Gynostemma pentaphyllum decreases hepatic glucose output in type 2 diabetic goto-kakizaki rats[J]. Int J Biomed Sci, 2011, 7(2):131-136.

[32] Huyen V T T, Phan D V, Thang P, et al. Antidiabetic effects of add-on Gynostemma pentaphyllum extract therapy with sulfonylureas in type 2 diabetic patients[J]. Evid-Based Compl Alt, 2012, doi:10.1155/2012/452313.

[33] Chou S C, Chen K W, Hwang J S, et al. The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease[J]. Altern Ther Health Med, 2006, 12(3):34-39.

[34] Huyen V T T, Phan D V, Thang P, et al. Antidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients[J]. Horm Metab Res, 2010, 42(5):353-357.

[35] Huyen V T T, Phan D V, Thang P, et al. Gynostemma pentaphyllum tea improves insulin sensitivity in type 2 diabetic patients[J]. J Nutr Metab, 2013, doi:10.1155/2013/765383.

[36] 张德芹, 张建军, 王景霞, 等. 芪蓝糖脂宁胶囊对实验性糖尿病合并高脂血症大鼠糖、脂代谢的影响[J]. 中国中药杂志, 2005, 30(10):773-777.

[37] Wei Y, Hong Y Z, Xun Y E. Effect of Tang No. 1 granule in treating patients with impaired glucose tolerance[J]. Chin J Integr Med, 2008, 14(4):298-302.

[38] 袁强, 余永华, 汪燕红, 等. 糖克宁颗粒的降糖降脂作用及其机理研究[J]. 中国现代应用药学杂志, 2009, 26(3):184-187.

[39] Tan Y, Kamal M A, Wang Z Z, et al. Chinese herbal extracts (SK0506) as a potential candidate for the therapy of metabolic syndrome[J]. Clin Sci, 2011, 120(7):297-305.

[40] 戚虹百, 杨坤, 高晨. 复方调脂降糖汤治疗糖尿病患者的临床观察[J]. 光明中医, 2018, 33(12):1748-1749.

[41] Zhou J C, Cai D K, Xie K F, et al. Mechanism of YLTZ on glycolipid metabolism based on UPLC/TOF/MS metabolomics[J]. J Chromatogr B, 2018, doi:10.1016/j.jchromb.2018.08.023.

[42] Wang Y J, Qi F C, Hao S M, et al. Expression of CTB-human insulin (BA) fusion protein in Gynostemma Pentapyhllum Makino callus cells and its hypoglycemic effect in mice[J]. Chem Res Chin Univ, 2010, 26(5):773-779.

[43] 赵笑笑, 张慧茹, 孟素香, 等. 绞股蓝内生真菌多糖对α-葡萄糖苷酶的抑制作用[J]. 食品科学, 2016, 37(17):70-75.

[44] Joshi S R, Standl E, Tong N, et al. Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus:An evidence-based review[J]. Expert Opin Pharmaco, 2015, 16(13):1959-1981.

[45] Adisakwattana S, Jiphimai P, Prutanopajai P, et al. Evaluation of α-glucosidase, α-amylase and protein glycation inhibitory activities of edible plants[J]. Int J Food Sci Nutr, 2010, 61(3):295-305.

[46] Yang F, Shi H M, Zhang X W, et al. Two new saponins from tetraploid jiaogulan (Gynostemma pentaphyllum), and their anti-inflammatory and α-glucosidase inhibitory activities[J]. Food Chem, 2013, 141(4):3606-3613.

[47] Ye X P, Song C Q, Yuan P, et al. α-Glucosidase and α-amylase inhibitory activity of common constituents from traditional Chinese medicine used for diabetes mellitus[J]. Chin J Nat Med, 2010, 8(5):349-352.

[48] Obanda D N, Cefalu W T. Modulation of cellular insulin signaling and PTP1B effects by lipid metabolites in skeletal muscle cells[J]. J Nutr Biochem, 2013, 24(8):1529-1537.

[49] Ji W, Chen X, Lv J, et al. Liraglutide exerts antidiabetic effect via PTP1B and PI3K/Akt2 signaling pathway in skeletal muscle of KKAy mice[J]. Int J Endocrinol, 2014, doi:10.1155/2014/312452.

[50] Hung T M, Hoang D M, Kim J C, et al. Protein tyrosine phosphatase 1B inhibitory by dammaranes from Vietnamese Giao-Co-Lam tea[J]. J Ethnopharmacol, 2009, 124(2):240-245.

[51] Xu J Q, Shen Q, Li J, et al. Dammaranes from Gynostemma pentaphyllum and synthesis of their derivatives as inhibitors of protein tyrosine phosphatase 1B[J]. Bioorg Med Chem, 2010, 18(11):3934-3939.

[52] Zhang X S, Bi X L, Xiao W, et al. Protein tyrosine phosphatase 1B inhibitory effect by dammarane-type triterpenes from hydrolyzate of total Gynostemma Pentaphyllum saponins[J]. Bioorg Med Chem Lett, 2013, 23(1):297-300.

[53] Kersten S. Integrated physiology and systems biology of PPARα[J]. Mol Metab, 2014, 3(4):354-371.

[54] Mansour M. The roles稠敯牦猠瑰潥牲景數物?偯???楰?敯瑬?慦汥??楴????楡潣浴潩汶敡捴略汤愠牲?捣桥慰牴慯捲瑳攠物楮稠慴瑨楥漠湭?潴晡?灯畬瑩慣琠楳癹敮?慲湯瑭楥摛楊慝戮攠琼楩挾?桲敯牧戠慍汯?攠硂瑩牯慬挠瑔獲孡?嵳???楩?倬?漲匰?伴測攠??楩??‰金???????????攭????????1- 1.00007-7.

[55] Kahremany S, Livne A, Gruzman A, et al. Activation of PPARδ:From computer modelling to biological effects[J]. Brit J Pharmacol, 2015, 172(3):754-770.

[56] 庞玉萍. 绞股蓝总皂苷对2型糖尿病大鼠游离脂肪酸代谢的影响及改善胰岛素抵抗相关机制研究[J]. 中华中医药学刊, 2016, 34(4):960-963.

[57] 贺琴, 雷飞飞, 李儒贵, 等. 绞股蓝皂苷降低2型糖尿病并非酒精性脂肪性肝病大鼠血糖、血脂的机理研究[J]. 湖北医药学院学报, 2013, 32(1):39-43.

[58] 谭华炳, 雷飞飞, 李儒贵. 绞股蓝皂苷对2型糖尿病并非酒精性脂肪性肝病大鼠过氧化物酶体增殖物激活受体γ表达影响[J]. 辽宁中医杂志, 2013, 40(8):1706-1709.

[59] Malek M A, Hoang M H, Jia Y, et al. Ombuin-3-O-β- d-glucopyranoside from Gynostemma pentaphyllum is a dual agonistic ligand of peroxisome proliferator-activated receptors α and δ/β[J]. Biochem Bioph Res Commun, 2013, 430(4):1322-1328.

[60] Arirachakaran A, Boonard M, Piyapittayanun P, et al. Post-operative outcomes and complications of suspensory loop fixation device versus hook plate in acute unstable acromioclavicular joint dislocation:A systematic review and meta-analysis[J]. J Orthop Traumatol, 2017, 18(4):293-304.

[61] Zhang M X, Du N, Wang L, et al. Conjugated fatty acid-rich oil from Gynostrmma pentaphyllum seed can ameliorate lipid and glucose metabolism in type 2 diabetes mellitus mice[J]. Food Funct, 2017, 8(10):3696-3706.

[62] Hardie G D. AMP-activated protein kinase:A key regulator of energy balance with many roles in human disease[J]. J Intern Med, 2014, 276(6):543-559.

[63] Novikova D S, Garabadzhiu A V, Melino G, et al. AMP-activated protein kinase:Structure, function, and role in pathological processes[J]. Biochemistry-Moscow, 2015, 80(2):127-144.

[64] Nguyen P H, Gauhar R, Hwang S L, et al. New dammarane-type glucosides as potential activators of AMP-activated protein kinase (AMPK) from Gynostemma pentaphyllum[J]. Bioorgan Med Chem, 2011, 19(21):6254-6260.

[65] Gauhar R, Hwang S L, Jeong S S, et al. Heat-processed Gynostemma pentaphyllum extract improves obesity in ob/ob mice by activating AMP-activated protein kinase[J]. Biotechnol Lett, 2012, 34(9):1607-1616.

[66] Dong C, Xie Z, Yu Y, et al. Discovery, synthesis, and structure-activity relationships of 20S-dammar-24-en-2α, 3β,12β,20-tetrol (GP) derivatives as a new class of AMPKα2β1γ1 activators[J]. Bioorg Med Chem, 2016, 24(12):2688-2696.

[67] Wang J, Ha T K Q, Shi Y P, et al. Hypoglycemic triterpenes from Gynostemma pentaphyllum[J]. Phytochemistry, 2018, doi:10.1016/j.phytochem.2018.08. 008.

[68] Pham H T T, Ha T K Q, Cho H M, et al. Insulin mimetic activity of 3,4-seco and hexanordammarane triterpenoids isolated from Gynostemma longipes[J]. J Nat Prod, 2018, 81(11):2470-2482.

[69] Petersen M C, Vatner D F, Shulman G I. Regulation of hepatic glucose metabolism in health and disease[J]. Nat Rev Endocrinol, 2017, 13(10):572-587.

[70] Rines A K, Sharabi K, Tavares C D J, et al. Targeting hepatic glucose metabolism in the treatment of type 2 diabetes[J]. Nat Rev Drug Discov, 2016, 15(11):786-804.

[71] Yeo J, Kang Y J, Jeon S M, et al. Potential hypoglycemic effect of an ethanol extract of Gynostemma pentaphyllum in C57BL/KsJ-db/db Mice[J]. J Med Food, 2009, 11(4):709-716.

[72] Krysiak R, Gdula-Dymek A, Marek B, et al. Comparison of the effects of hypolipidemic treatment on monocyte proinflammatory cytokine release in men and women with type 2 diabetes and atherogenic dyslipidemia[J]. Endokrynol Pol, 2015, 66(3):224-230.

[73] Lou P H, Lucchinetti E, Scott K Y, et al. Alterations in fatty acid metabolism and sirtuin signaling characterize early type-2 diabetic hearts of fructose-fed rats[J]. Physiolo Rep, 2017, 5(16):1-20.

[74] Müller C, Gardemann A, Keilhoff G, et al. Prevention of free fatty acid-induced lipid accumulation, oxidative stress, and cell death in primary hepatocyte cultures by a Gynostemma pentaphyllum extract[J]. Phytomedicine, 2012, 19(5):395-401.

[75] Bai M S, Gao J M, Fan C, et al. Bioactive dammarane- type triterpenoids derived from the acid hydrolysate of Gynostemma pentaphyllum saponins[J]. Food Chem, 2010, 119(1):306-310.

[76] Karlsson F, Tremaroli V, Nielsen J, et al. Assessing the human gut microbiota in metabolic diseases[J]. Diabetes, 2013, 62(10):3341-3349.

[77] Liu J, Li Y F, Yang P Y, et al. Gypenosides reduced the risk of overweight and insulin resistance in C57BL/6J mice through modulating adipose thermogenesis and gut microbiota[J]. J Agr Food Chem, 2017, 65(42):9237-9246.

[78] Naruse R, Hori K I, Terasawa T, et al. Alterations of plant sterols, lathosterol, oxidative stress and inflammatory markers after the combination therapy of ezetimibe and statin drugs in type 2 diabetic patients[J]. Obes Res Clin Pract, 2015, 9(1):67-74.

[79] Šamec D, Valek-Žxulj L, Martinez S, et al. Phenolic acids significantly contribute to antioxidant potency of Gynostemma pentaphyllum aqueous and methanol extracts[J]. Ind Crop Prod, 2016, doi:10.1016/j.indcrop. 2016.01.035.

[80] Gao D W, Zhao M, Qi X M, et al. Hypoglycemic effect of Gynostemma pentaphyllum saponins by enhancing the Nrf2 signaling pathway in STZ-inducing diabetic rats[J]. Arch Pharm Res, 2016, 39(2):221-230.

[81] Esser N, Legrand-Poels S, Piette J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes[J]. Diabetes Res Clin Pract, 2014, 105(2):141-150.

[82] 闵怀臻, 贺琴, 李金科, 等. 绞股蓝皂苷对2型糖尿病并NAFLD大鼠肝组织TNF-α mRNA表达和血硫化氢的影响[J]. 湖北医药学院学报, 2013, 32(4):317-320.

[83] He Q, Li J K, Li F, et al. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats[J]. World J Gastroentero, 2015, 21(7):2058-2066.

[84] Stadlbauer V, Haselgrübler R, Lan